AxioMed Achieves Landmark Patent for its Lateral Disc
September 17, 2021
AxioMed continues to press its advantages in the artificial total disc replacement market with its investment in lateral disc technology.
​
At a time when revenues and margins are driving the spine industry, AxioMed chose to venture alone into developing a lateral viscoelastic disc replacement.
​
​We thank the United States Patent and Trademark Office (USPTO) for recognizing this unique, differentiated technology and giving us their approval for this patent.
AxioMed Lateral Viscoelastic Disc Replacement Patent
KICVentures Group CEO and board-certified orthopedic spine surgeon Dr. Kingsley R Chin MD expresses his sense of urgency in bringing the lateral disc to market beginning in Europe as early as 2023.
About AxioMed
AxioMed was founded in 2001 by surgeons at Cleveland Clinic and engineers who previously worked with Dr. Art Steffee and Acroflex viscoelastic disc replacement. The current AxioMed disc comprises of a proprietary silica-based viscoelastic material proven in extensive biomedical/biocompatible testing to mimic the human disc in all planes and 50+ years of longevity testing. The viscoelastic material is radiolucent and thus X-ray and MRI compatible. Over 800 discs have been implanted worldwide with zero device failures or revisions. It is the only viscoelastic lumbar disc to complete a USA IDE clinical study with 10+ years of follow-up.
https://www.axiomed.com/
Authors
​
Dr. Kingsley R. Chin MBA is a board-certified Professor of Orthopedic Spine Surgery and honors graduate of Harvard Medical School and the Harvard Combined Orthopedic Residency Program. He did his spine fellowship with Dr. Henry H Bohlman. He was Chief of Spine Surgery at the University of Pennsylvania.
​
​
Dr. Jason A. Seale MBA is a medical doctor and entrepreneur. He is the clinical director at the LES Clinic. He holds a Masters in Business Administration degree